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The biocatalytic approach to the preparation of 
Pramipexole
INTRODUCTION
Saccharomyces cerevisiae
AIM OF WORK
Experimental 
conditions
Time (h) Conversion (%) (R) e.e. 
(%)
buffer pH 7 18 100 92
buffer pH 7/n-
heptane 1:1
18 100 94
buffer pH 7/n-
heptane 1:1
16 87 >98
BENZIL REDUCTASE3 from Pichia glucozyma 4
BEST BIOTRANSFORMATION CONDITIONS 
• Phosphate buffer 100 mM, pH 7
• S. cerevisiae liophilized whole cells 14 g/L
• Saccarose 50 g/L
• Substrate: keto-intermediate 2,5 g/L
• eptane/water phase 1:1
Under stirring at 30°C, 180 rpm.
* Determinated by HPLC on chiral stationary phase.
BIOTRANSFORMATION CONDITION 
- Benzil reductase
- Glucose dehydrogenase
- Substrate: keto-intermediate 1 g/L
- Glucose
- Tris HCl buffer 50 mM, pH8
- NADP+
Under stirring at 30°C for 24h, 150 rpm.
Glucose
+
BR
NADPH NADP
GDH
Gluconolactone
In this new synthetic way reduction of the prochiral
ketone represents the key point to achieve an
enantomerically pure pramipexole.
The biocatalytic preparation of optically pure chiral
building blocks is a valid alternative to conventional
chemical methods.
CHEMICAL SYNTHESIS DEVELOPED
R or S R or S S or R S or R S or R S or R
Through screening for ketoreductase activity we are going to
identify biocatalysts with marked enantioselectivity, in order to
obtain both optically pure alcohols.
* Determinated by HPLC on chiral stationary phase.
* benedetta.guidi@unimi.it
(R)-Pramipexole is currently in clinical development for the treatment
of AMYOTROPHIC LATERAL SCLEROSIS (ALS).
PRAMIPEXOLE
Two enantiomers of the same molecule show a different biological activity.
CONCLUSIONS
• The common baker yeast Saccharomyces cerevisiae afforded with
yields of 80% optically pure (R)-alcohol precursor of the anti-Parkinson
(S)-pramipexole. The optically pure (S)-alcohol, required for the
synthesis of (R)-pramipexole, under investigation for the treatment of
ALS, has been isolated with low yields by inversion of configuration
from (R)-alcohol.
• Twenty marine yeast strains were screened for ketoreductase activity
with the aim of reducing the ketone with a stereochemical outcome
opposite than S.cerevisiae, affording (S)-alcohol. In particular,
Rhodotorula mucillaginosa strains gave (S)-alcohol with an e.e. ranging
from 38% to 64%.
• Application of a novel benzil reductase from Pichia glucozyma, thanks
to co-factor recycling system, showed that isolated enzyme is able to
produce (S)-alcohol with e.e. 86% .
FUTURE DEVELOPMENTS
• Optimisation of marine yeasts biotransformation conditions .
• Screening of new microorganisms.
• Isolation, cloning and expression of the best performing proteins from microorganism screened
active on the suitable ketone.
• Setting up a continuous baker yeast catalysed biotransformation based on Flow Chemistry
technique.
(S)-Pramipexole is the most prescribed dopamine agonist in the
ANTI-PARKINSON THERAPY.
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Microorganisms Identificati
on number
T (h) Conversion
*
e.e.* Configuration
Meyerozyma guilliermondii strain 1 24 100% 7,5% R
Meyerozyma guilliermondii strain 2 24 100% 5% R
Meyerozyma guilliermondii strain 3 24 100% 1,3% R
Rhodotorula mucilaginosa strain 4 24 100% 40% S
Meyerozyma guilliermondii strain 5 24 100% 2% R
Meyerozyma guilliermondii strain 6 24 100% 1% R
Not sequenced 7 24 84% 26% R
Rhodotorula mucilaginosa strain 8 24 100% 45% S
Rhodotorula mucilaginosa strain 9 24 100% 0,15% S
Rhodotorula mucilaginosa strain 10 24 100% 42% S
Rhodotorula mucilaginosa strain 13 24 100% 62% S
Rhodotorula mucilaginosa strain 14 24 98% 50% S
Rhodotorula mucilaginosa strain 15 24 100% 56% S
Rhodotorula mucilaginosa strain 16 24 100% 64% S
Rhodotorula mucilaginosa strain 17 24 100% 48% S
Rhodotorula mucilaginosa strain 18 24 100% 38% S
Rhodotorula mucilaginosa strain 19 24 100% 48% S
Rhodotorula mucilaginosa strain 20 24 100% 50% S
Rhodotorula mucilaginosa strain 21 24 100% 50% S
Rhodotorula mucilaginosa strain 22 24 100% 49% S
* Determinated by HPLC on chiral stationary phase.
MARINE YEASTS
PRELIMINARY BIOTRANSFORMATION CONDITIONS 
Under stirring at 30°C,180 rpm.
• Growing cells after 48h in YPD+3% NaCl
• Glucose 50 g/L
• Substrate: keto-intermediate 1 g/L (isopropanol)
Screening on twenty marine yeast strains,  
from MaCuMBA1 European project collection2.
+
+2
0 h 2,5 h 4 h
Conversion* 15% 67% 75%
(S) e.e.* 43% 53% 86%
(S)-alcohol
RESULTS RESULTS
(S)-alcohol
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